{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:39:55Z","timestamp":1791905995981,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009856","name":"LK Whittier Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cell.2026.05.043","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:38:05Z","timestamp":1781879885000},"page":"5378-5395.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Shi","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan A.","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Contreras-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xugeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiri","family":"Ediriwickrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Koschade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"McKim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5822-9498","authenticated-orcid":false,"given":"Qi-Long","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.05.043_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.05.043_bib2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.05.043_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41577-025-01229-3","article-title":"Microenvironmental regulation of solid tumour resistance to CAR T cell therapy","volume":"26","author":"Lamplugh","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.05.043_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.05.043_bib5","article-title":"Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","volume":"16","author":"Pierini","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.05.043_bib6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.05.043_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2026.05.043_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-025-03359-x","article-title":"Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?","volume":"44","author":"Bhatia","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.05.043_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ccell.2025.06.014","article-title":"Engineering myeloid cells for cancer immunotherapy","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s002620100224","article-title":"Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma","volume":"50","author":"Quillien","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2026.05.043_bib11","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.05.043_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","article-title":"CAR-macrophages in solid tumors: promise, progress, and prospects","volume":"9","author":"Alrehaili","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.cell.2026.05.043_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.05.043_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/vim.2019.0182","article-title":"A Disquisition on MHC Restriction and T Cell Recognition in Five Acts","volume":"33","author":"Greenspan","year":"2020","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cell.2026.05.043_bib15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","article-title":"Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors","volume":"163","author":"Paul","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.05.043_bib17","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.172384399","article-title":"Prospective isolation of human clonogenic common myeloid progenitors","volume":"99","author":"Manz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.05.043_bib18","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1158\/0008-5472.CAN-08-3563","article-title":"Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase\/mitogen-activated protein kinase pathway suppression","volume":"69","author":"Hoeflich","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.05.043_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cr.2011.127","article-title":"Small molecule-based disruption of the Axin\/beta-catenin protein complex regulates mesenchymal stem cell differentiation","volume":"22","author":"Gwak","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2026.05.043_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-0716-0696-4_29","article-title":"Identification of Murine Basophils by Flow Cytometry and Histology","volume":"2163","author":"Schwartz","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2026.05.043_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/JLB.1AB0519-170RR","article-title":"More than neutrophils: Lin(+)Ly6G(+)IL-5R\u03b1(+) multipotent myeloid cells (MMCs) are dominant in normal murine bone marrow and retain capacity to differentiate into eosinophils and monocytes","volume":"111","author":"Jeong","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cell.2026.05.043_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2021.780778","article-title":"A Low-Serum Culture System for Prolonged in Vitro Toxicology Experiments on a Macrophage System","volume":"3","author":"Dalzon","year":"2021","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.cell.2026.05.043_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2000.01956.x","article-title":"Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction","volume":"108","author":"Ardeshna","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cell.2026.05.043_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41590-017-0001-2","article-title":"Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells","volume":"19","author":"Karamitros","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2026.05.043_bib25","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood.V97.12.3738","article-title":"Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease","volume":"97","author":"Dinauer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.05.043_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36688","article-title":"Chimeric antigen receptors that trigger phagocytosis","volume":"7","author":"Morrissey","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.cell.2026.05.043_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical Role for CD103+\/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cell.2026.05.043_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wsbm.86","article-title":"Hematopoietic stem cell: self-renewal versus differentiation","volume":"2","author":"Seita","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.cell.2026.05.043_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00262-006-0181-3","article-title":"In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma","volume":"56","author":"Ritchie","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2026.05.043_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1189\/jlb.0206110","article-title":"Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery","volume":"80","author":"Gorantla","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cell.2026.05.043_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/icb.2016.121","article-title":"Role of Fc-Fc\u03b3R interactions in the antitumor activity of therapeutic antibodies","volume":"95","author":"Barnhart","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cell.2026.05.043_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.stem.2025.03.004","article-title":"Progress and challenges in developing allogeneic cell therapies","volume":"32","author":"Deuse","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib34","article-title":"Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit \u2018ALL\u2019","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.05.043_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cell.2026.05.043_bib36","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1182\/bloodadvances.2024013044","article-title":"CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations","volume":"8","author":"Perna","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2026.05.043_bib37","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2013-11-492231","article-title":"Antibody-modified T cells: CARs take the front seat for hematologic malignancies","volume":"123","author":"Maus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.05.043_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.05.043_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.trecan.2025.08.014","article-title":"CAR T cell persistence in cancer","volume":"11","author":"Mueller","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cell.2026.05.043_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1667\/RR2894.1","article-title":"Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation","volume":"177","author":"Singh","year":"2012","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cell.2026.05.043_bib41","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.20.01739","article-title":"Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia","volume":"39","author":"Desai","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.05.043_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1702543","article-title":"Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue","volume":"26","author":"Zimmerman","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cell.2026.05.043_bib43","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.cell.2026.05.043_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"GigaScience"},{"key":"10.1016\/j.cell.2026.05.043_bib46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.molcel.2020.04.008","article-title":"Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets","volume":"78","author":"Psaila","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.05.043_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/2643-3230.BCD-21-0143","article-title":"The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia","volume":"3","author":"Nakauchi","year":"2022","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.cell.2026.05.043_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30440-2","article-title":"Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells","volume":"13","author":"Itokawa","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.05.043_bib49","series-title":"Cell Biology: A Laboratory Handbook","first-page":"391","article-title":"Basic cytogenetic techniques: culture, slidemaking and banding","author":"Hsieh","year":"1997"},{"key":"10.1016\/j.cell.2026.05.043_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3674","article-title":"Construction and evaluation of a novel humanized HER2-specific chimeric receptor","volume":"16","author":"Sun","year":"2014","journal-title":"Breast Cancer Res."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426006434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426006434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:36:31Z","timestamp":1790829391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426006434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0092867426006434"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.05.043","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}